It has been proposed that the immunotherapeutic role of CD8+ MAIT cells in lung cancer is mediated, at least in part, by interactions with classical and non-classical monocytes via the CXCL16–CXCR6 axis [68,69]. The gene discussed is CXCR6; the disease is lung carcinoma.